These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 11419867

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
    Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H.
    J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
    Fujita N, Kaito M, Kai M, Sugimoto R, Tanaka H, Horiike S, Konishi M, Iwasa M, Watanabe S, Adachi Y.
    J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis C: not so indolent in survivors of pediatric cancer?
    Schwarz KB.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):7. PubMed ID: 20486163
    [No Abstract] [Full Text] [Related]

  • 32. [Similar poor response in genotype 4 chronic Hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment].
    Pérez Mota A, Graus J, García Flores MA, Blanco M, Pérez-Muñoz C, Villalgordo C, Rodero R.
    Rev Esp Enferm Dig; 2003 Mar 15; 95(3):238-9. PubMed ID: 12760714
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
    Pol S.
    Gastroenterol Clin Biol; 2002 Apr 15; 26 Spec No 2():B264-73. PubMed ID: 12180300
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
    Hofer H, Osterreicher C, Jessner W, Penz M, Steindl-Munda P, Wrba F, Ferenci P.
    J Hepatol; 2004 Jun 15; 40(6):1018-22. PubMed ID: 15158344
    [Abstract] [Full Text] [Related]

  • 37. Up to date treatment of hepatitis C in adults.
    Schalm SW, Brouwer JT.
    Acta Gastroenterol Belg; 1998 Jun 15; 61(4):397-9. PubMed ID: 9923088
    [No Abstract] [Full Text] [Related]

  • 38. Effectiveness of conventional interferon and ribavirin combination therapy in chronic Hepatitis C patients in Pakistan.
    Bukhsh A, Goh BH, Lee LH, Khan TM.
    J Infect Public Health; 2017 Jun 15; 10(5):692-693. PubMed ID: 28209323
    [No Abstract] [Full Text] [Related]

  • 39. Combination treatment for hepatitis C is not being given.
    Foster GR, Chapman R.
    BMJ; 2000 Oct 07; 321(7265):899. PubMed ID: 11021891
    [No Abstract] [Full Text] [Related]

  • 40. [Interferons and chronic hepatitis C treatment].
    Cai DC, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov 07; 15(11):847-8. PubMed ID: 18073070
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.